The purpose of this work is to develop a novel, tumor-selective dual-contrast 3D MRI technique that can clearly differentiate small brain metastases from contrast-enhanced vessels while potentially eliminating false-positiveness in the corresponding diagnosis. After injecting contrast agents, the proposed pulse sequence employs a pair of mixed encodings in each TR, yielding highly tumor-selective, blood-suppressed images from the latter to increase the sensitivity of metastases detection while producing blood-enhanced signals from the former to evaluate the false-positiveness of the detected metastases. It is expected that the proposed method enhances detection sensitivity to brain metastases while substantially reducing false-positiveness.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords